Volume 1 Number 2

Website Exclusive Contents!
Exclusive contents: images and/or videos
• Endovascular treatment of popliteal artery occlusion caused by cystic adventitial degeneration
Do KC, Diehm N, Triller J, Schmidli J, Do DD, Mahler F
• Controlled blunt microdissection for percutaneous recanalisation of a subclavian artery chronic total occlusion
Mossop P, Amukotuwa S, Whitbourn R
• Echo-guided, super-selective septal ablation for HOCM
Faber L, Welge D, Buschler B, Schmidt H, Horstkotte D
Editorial
16
Introduction and thoughts on the second issue of EuroIntervention
Serruys PW
EuroInterv.2005;2:121
17
Coin of the realm: do only randomized trials count or is ART okay?
Holmes DR
EuroInterv.2005;2:122
18
The Endeavor Stent System: will it be the next kid in the block? Numero uno, first among equals or equal?
Waksman R
EuroInterv.2005;2:123-124
19
Blowing against the wind?
Wijns W
EuroInterv.2005;2:125-127
20
Beyond crossing a chronic total occlusion. Are the drug-eluting stents the solution for this old problem?
García-García H, Valgimigli M, Lotan C
EuroInterv.2005;2:129-131
Working Group 10 column
21
Launching a new journal dedicated to interventional cardiology is a great challenge.
Lafont A
EuroInterv.2005;2:133
22
Training in interventional cardiology in Europe: how to move from chaos to rational common programs?
Di Mario C, Lafont A
EuroInterv.2005;2:135-137
Special Article
23
EuroPCR highlights 2005
Malagutti P, Valgimigli M, de Feyter PJ, on behalf of the EuroPCR Board
EuroInterv.2005;2:139-144
24
EuroIntervention: a politician's view
Douste-Blazy P
EuroInterv.2005;2:145-146
Clinical Research
25
Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novocoronary artery lesions
Serruys PW, Ong ATL, Morice M-C, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, James A, Bressers M, Donohoe D, on behalf of the ARTS II Investigators
EuroInterv.2005;2:147-156
26
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial
Meredith I, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma J, Cutlip D, Fitzgerald P, Prpic R, Kuntz R
EuroInterv.2005;2:157-164
27
One-year clinical outcome of various doses and pharmacokinetic release of paclitaxel eluted from an erodable polymer - Insights from the Paclitaxel In-Stent Controlled Elution Study (PISCES)
Aoki J, Ong ATL, Abizaid A, den Heijer P, Bonnier H, McClean DR, Verheye S, Belardi J, Condado J, Pieper M, Eduardo Sousa J, Bressers M, Symons J, Litvack F, Sianos G, Serruys PW
EuroInterv.2005;2:165-172
28
Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study
Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati F, Crea F, Vassanelli C
EuroInterv.2005;2:173-180
29
Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery
Michels M, Caliskan K, Ong ATL, McFadden E, Kappetein AP, van Domburg RT, Serruys PW
EuroInterv.2005;2:181-185
30
Early and late results of percutaneous revascularization in patients with ischemic cardiomyopathy and decreased left ventricular ejection fraction. (Revascularisation in Heart Failure Trial, REHEAT Registry)
Buszman P, Szkróbka I, Tendera Z, Gruszka A, Bialkowska B, Parma R, Wojakowski W, Król M, Kiesz SR, Bochenek A, Tendera M
EuroInterv.2005;2:186-192
31
Drug-eluting stent implantation for chronic total occlusions: comparison between the Sirolimus- and Paclitaxel-eluting stent
Hoye A, Ong ATL, Aoki J, van Mieghem CAG, Rodríguez-Granillo G, Valgimigli M, Sianos G, McFadden E, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW
EuroInterv.2005;2:193-197
32
Primary stenting for left-main shock syndrome
Yamane M, Inoue S, Yamane A, Kinebuchi O, Yokozuka H
EuroInterv.2005;2:198-203
33
150 microgram intracoronary adenosine bolus for accurate fractional flow reserve assessment of angiographically intermediate coronary stenosis
Rioufol G, Caignault J-R, Finet G, Staat P, Bonnefoy E, de Gévigney G, Rossi R, André-Fouët X
EuroInterv.2005;2:204-207
34
Preprocedural creatinine clearance and long term survivalafter successful coronary stenting
Souibri K, Morello R, Fradin S, Grollier G, Ryckelynck J-P, Hamon M
EuroInterv.2005;2:208-213
35
CMR assessment of AMI patients treated by PCI shows delays in myocardial reperfusion despite initial achievement of TIMI 3 flow
Noël B, Morice M-C, Garot J, Louvard Y, Tavolaro O, Dumas P, Lévy M, Garot P, Lefčvre T
EuroInterv.2005;2:214-218
36
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease
Sianos G, Morel M-A, Kappetein AP, Morice M-C, Colombo A, Dawkins K, van den Brand M, van Dyck N, Russell ME, Serruys PW
EuroInterv.2005;2:219-227
Experimental research
37
The effect of variable release kinetics on Paclitaxel efficacy from a drug eluting stent in a porcine model
Aragon J, Kar S, Tio F, Trauthen B, Parisky A, Watanabe C, Jamali A, Eigler N, Serruys PW, Litvack F
EuroInterv.2005;2:228-235
38
Inhibition of intimal hyperplasia by the tetracycline derived MMP inhibitor doxycycline in vein graft disease in vitro and in vivo
Lardenoye JHP, de Vries MR, Deckers M, van Lent N, Hanemaaijer R, van Bockel JH, Quax PHA
EuroInterv.2005;2:236-243
New Devices
39
Assessment of stent dimensions with a novel intracoronary balloon-based system: comparative study versus intravascular ultrasound and quantitative coronary angiography. The CAMUS - Coronary Angioplasty Metricath vs. UltraSound Trial
van der Giessen WJ, Regar E, McFadden E, McDougall I, Serruys PW
EuroInterv.2005;2:244-251
Volume 1 Number 2 has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • Boston Scientific
  • Conor Medsystems
  • Cordis, a Johnson & Johnson company
  • Medtronic
  • Mentice AB
  • Siemens Medical
  • Terumo

Online ISSN 1969-6213 - Print ISSN 1774-024X